PortfoliosLab logoPortfoliosLab logo
NCSM vs. BLUE
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Financials

Performance

NCSM vs. BLUE - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in NCS Multistage Holdings, Inc. (NCSM) and bluebird bio, Inc. (BLUE). The values are adjusted to include any dividend payments, if applicable.

Loading graphics...

NCSM vs. BLUE - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
NCSM
NCS Multistage Holdings, Inc.
52.47%52.12%45.43%-28.60%-13.76%28.79%-46.40%-58.74%-65.47%-26.34%
BLUE
bluebird bio, Inc.
0.00%-40.41%-69.78%-80.06%-30.73%-64.35%-50.69%-11.54%-44.30%100.22%

Fundamentals

Total Revenue (TTM)

NCSM:

$183.63M

BLUE:

$103.95M

Gross Profit (TTM)

NCSM:

$75.43M

BLUE:

$28.19M

EBITDA (TTM)

NCSM:

$19.22M

BLUE:

-$115.82M

Returns By Period


NCSM

1D
-2.64%
1M
47.10%
YTD
52.47%
6M
18.06%
1Y
66.51%
3Y*
36.45%
5Y*
18.14%
10Y*

BLUE

1D
1M
YTD
6M
1Y
3Y*
5Y*
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

NCSM vs. BLUE — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

NCSM
NCSM Risk / Return Rank: 7272
Overall Rank
NCSM Sharpe Ratio Rank: 7373
Sharpe Ratio Rank
NCSM Sortino Ratio Rank: 7272
Sortino Ratio Rank
NCSM Omega Ratio Rank: 7070
Omega Ratio Rank
NCSM Calmar Ratio Rank: 7777
Calmar Ratio Rank
NCSM Martin Ratio Rank: 6969
Martin Ratio Rank

BLUE
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

NCSM vs. BLUE - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for NCS Multistage Holdings, Inc. (NCSM) and bluebird bio, Inc. (BLUE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


NCSMBLUEDifference

Sharpe ratio

Return per unit of total volatility

0.98

Sortino ratio

Return per unit of downside risk

1.74

Omega ratio

Gain probability vs. loss probability

1.22

Calmar ratio

Return relative to maximum drawdown

2.13

Martin ratio

Return relative to average drawdown

3.43

NCSM vs. BLUE - Sharpe Ratio Comparison


Loading graphics...

Sharpe Ratios by Period


NCSMBLUEDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

0.98

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.30

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.25

Correlation

The correlation between NCSM and BLUE is 0.08, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Dividends

NCSM vs. BLUE - Dividend Comparison

Neither NCSM nor BLUE has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

NCSM vs. BLUE - Drawdown Comparison


Loading graphics...

Drawdown Indicators


NCSMBLUEDifference

Max Drawdown

Largest peak-to-trough decline

-98.58%

Max Drawdown (1Y)

Largest decline over 1 year

-33.80%

Max Drawdown (5Y)

Largest decline over 5 years

-78.56%

Current Drawdown

Current decline from peak

-88.87%

Average Drawdown

Average peak-to-trough decline

-83.10%

Ulcer Index

Depth and duration of drawdowns from previous peaks

21.00%

Volatility

NCSM vs. BLUE - Volatility Comparison


Loading graphics...

Volatility by Period


NCSMBLUEDifference

Volatility (1M)

Calculated over the trailing 1-month period

31.33%

Volatility (6M)

Calculated over the trailing 6-month period

48.11%

Volatility (1Y)

Calculated over the trailing 1-year period

68.47%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

60.47%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

77.28%

Financials

NCSM vs. BLUE - Financials Comparison

This section allows you to compare key financial metrics between NCS Multistage Holdings, Inc. and bluebird bio, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0010.00M20.00M30.00M40.00M50.00MAprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober
50.63M
38.71M
(NCSM) Total Revenue
(BLUE) Total Revenue
Values in USD except per share items